A postgraduate research opportunity at the University of Otago.
- Close date
- Friday, 23 February 2018
- Academic background
- Sciences, Health Sciences
- Host campus
- Pathology and Biomedical Science (Christchurch)
- Professor Mark Hampton
Multicellular organisms have carefully regulated death programs to remove damaged or unwanted cells. Faults in these programs contribute to human disease. Apoptosis is the best-studied cell death program, and drugs have been designed to promote apoptosis in cancer cells. Necroptosis is a newly recognised cell death program, and while it is thought to play an important role in various diseases, relatively little is understood about the mechanisms of necroptosis and how the process is controlled.
Our research indicates that mitochondrial changes occur early in cells in which necroptosis is triggered, and that certain cellular proteins become oxidized. An honours project is available to investigate early biochemical events in the signalling pathways leading to necroptosis. Of particular interest is the protein MLKL, and how activation of this protein causes the mitochondrial changes and protein oxidation that we have observed. This project is funded by the Royal Society Marsden Fund and would occur in close collaboration with investigators from the Walter & Eliza Hall Institute in Melbourne. Students would learn how to culture cells, use flow cytometry and live-cell microscopy to measure cell death, and use a selection of biochemical techniques to measure signalling events inside the cells.
Preferred student expertise
Biochemistry, cell biology or related area
This project is one of the many available for the 2018 intake of BBiomedSc(Hons) at the University of Otago, Christchurch campus.
- Visit the University of Otago, Christchurch website for more information about the Honours programme
- Visit Professor Mark Hampton's staff profile
ContactProfessor Mark Hampton
Tel 64 3 378 6225